Member Info for inanaco

deflect ?

hardly

Ruck

Bermuda, Tf and myself all highlight ... your "incorrect version" of Royalties

Ruckrover ...

Correct me if I’m wrong but I don’t recollect anyone in 7 years, on any board ever criticising the science

really .......... ??????

so ONW did not throw jelly spanners ...

PMSL

C7 ... well having built an investment vehicle that allowed me to pretty well retire at 45 ... i could not possibly comment about Ruck ....
But if he cannot understand the basics .. of a Royalty ... surly eyebrows need raising

Bermuda will remember his post that linked valuations to cost of R and D ... Indeed it was Bermuda and myself that Questioned his understanding ... after all so much R and D in cancer research gets lost without discovery ...

I am sorry but posters that feel "entitled" to be right by posting to appear smart, often are not ... its mainly waffle

thats the important Bit .......

as I say we have enough irons in the fire, I believe, for that to change quickly

best ignore Rucks ... the Science failure posts ..

well ruck ....

I don’t think anyone should rule out £8 per share,

so its not Pie in the Sky then ... ?

Ruckrover

You mean an

advance against royalties ??

for that you need full approval ...

you can then contract to be paid your Royalties in Advance ie an Estimate ... however if they don't get the sales quick enough, your going to have to wait for the second "advance"

more than happy to have sensible conversions ... C7 ....

but take Ivy's last post .......... half a page of saying nothing ...

you cannot really expect a discussion on that surely ... getting posters involved is difficult enough and most really are happy to wait it out ... but the old clan still Pop in now again and are still Buyers ..

BobBust
Wildforce ....
etc

C7 ............ trying to help ...

read this post again ...

lets change the topic ...

Have you accepted that the Human Data Collected by SCIB1 and Keytruda's trials ... came First ..

giving the hypothesis of synergy

then they proved up that synergy in the mouse for regulatory submission ...

Now Think about it ... From Human Data they worked out that Keytruda "WILL" lock onto our Cd8 t cells ..

because if it didn't keytruda would never have been approved ... it would have failed completely ..

SCIB1 works ...

CRUK has Green Lighted SCIB2 ... and is spending the money

Crumbs they are the same antigens generated by citrullination and Homocitrulline

Its process specific ie Citrullinated cell meets inflammation then presents the "marker" ie the epitope

from the cancers point of view its Cellular structure specific but the major cancers are all based on this lineage

Vimentin is a type III intermediate filament (IF) protein that is expressed in mesenchymal cells

Not Patient specific

have you thought about this ...

Modi1 treats multiple cancers ........ if your treated for one and generate memory against re challenge ...

you CANNOT develop the other cancers Modi1 treats

lets change the topic ...

Have you accepted that the Human Data Collected by SCIB1 and Keytruda's trials ... came First ..

giving the hypothesis of synergy

then they proved up that synergy in the mouse for regulatory submission ...

Bermuda ...
I am sure you don't need to ask

16.23

its called Differential ...

Differential CD4(+)

open your eyes ............ MAB2811

You want to live to old age ? ........... you need these ........... Cytotoxic CD4 ...

this £8 plus is trial dependent ....

Lindy is "mastering" this sector ....

CD4 ..... She really has become the world expert on the most complex T cell in the immune system

and Ivy Ruck ONW .... etc just don't have any idea of the value of "helper T cells" .. even Hollywood has made Movies about them

"transformers"

why after i had already pointed them out and Tf concurred ... ???

why are you now going to try and understand statements that are wrong ... ?

makes no sense ..

C7 ... you have "watched" the explosive growth in the Check Points ...................
Scancell has synergy
and
Alternatives ..

so don't knock £8 a share when you have so many potential targets across 3 platforms

The global cancer therapy market was valued at USD 136,254.35 "million" .... in 2018

Bermuda

because its a complete sentence ..

We have been talking about “deals” for over 7 years. None of them have materialised to date. Personally, I have discounted them from my projections

I have discounted "them"

he posts utter nonsense on Royalties .. despite you and me explaining them in detail .. so he clearly cannot remember

so how can you trust his "expectations of value"

25p a share ?

based on the selling price of $40,000 a treatment course

Bermuda comes out and Changes what is written to suit ...........

"Do You Mean"

You did that the other day Bermuda ... "" twisting the debate to suit ""

what a stupid statement .........

""""We have been talking about “deals” for over 7 years. None of them have materialised to date. Personally, I have discounted them from my projections.""""

if that is the case why stay invested ???

because your not going to get any return without deals ....

Scancell is not geared to run to a phase 3 ...

and certainly not in about 20 plus Targets cancers